ID

25733

Descrizione

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Cognitive Function Substudy.

Keywords

  1. 15/09/17 15/09/17 -
  2. 21/09/17 21/09/17 -
  3. 13/10/17 13/10/17 -
  4. 23/10/17 23/10/17 -
  5. 20/12/17 20/12/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

15 settembre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Cognitive Function Substudy GSK study Chronic Coronary Heart Disease NCT00799903

Cognitive Function Substudy GSK study Chronic Coronary Heart Disease NCT00799903

Cognitive Function Eligibility Question
Descrizione

Cognitive Function Eligibility Question

1. Did the subject meet all the Cognitive Function substudy entry criteria?
Descrizione

No, please select all boxes corresponding to violations of any inclusion/exclusion criteria

Tipo di dati

text

[I08] Cognitive Function 1. Signed written informed consent prior to beginning substudy-related procedures (subject must understand the aims, investigational procedures and possible consequences of the substudy).
Descrizione

Inclusion criterion. Note: Consent to participate in the substudy is separate from consent to participate in the parent study.

Tipo di dati

boolean

[I09] Cognitive Function 2. Adequate vision and hearing for neuropsychological testing.
Descrizione

Inclusion criterion.

Tipo di dati

boolean

[E22] Cognitive Function 1. High level of cognitive function as assessed by a score of >50 on the Symbol Digit Modalities Test.
Descrizione

Exclusion criterion.

Tipo di dati

boolean

[E23] Cognitive Function 2. Significant deficit in verbal intelligence as assessed by Adult Reading Test score <85.
Descrizione

Exclusion criterion.

Tipo di dati

boolean

[E24] Cognitive Function 3. Aphasia
Descrizione

Exclusion criterion.

Tipo di dati

boolean

[E25] Cognitive Function 4. Inability to perform the test due to significant weakness in dominant hand.
Descrizione

Exclusion criterion.

Tipo di dati

boolean

Cognitive Function substudy
Descrizione

Cognitive Function substudy

1. Cognitive function testing completed
Descrizione

cognitive function testing completed

Tipo di dati

text

1. Date cognitive function testing completed
Descrizione

Date cognitive function testing

Tipo di dati

date

Similar models

Cognitive Function Substudy GSK study Chronic Coronary Heart Disease NCT00799903

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Cognitive Function Eligibility Question
Item
1. Did the subject meet all the Cognitive Function substudy entry criteria?
text
Code List
1. Did the subject meet all the Cognitive Function substudy entry criteria?
CL Item
Yes (Y)
CL Item
No, please select all boxes corresponding to violations of any inclusion/exclusion criteria (N)
Informed consent
Item
[I08] Cognitive Function 1. Signed written informed consent prior to beginning substudy-related procedures (subject must understand the aims, investigational procedures and possible consequences of the substudy).
boolean
Vision and hearing
Item
[I09] Cognitive Function 2. Adequate vision and hearing for neuropsychological testing.
boolean
High level cognitive function
Item
[E22] Cognitive Function 1. High level of cognitive function as assessed by a score of >50 on the Symbol Digit Modalities Test.
boolean
deficit in verbal intelligence
Item
[E23] Cognitive Function 2. Significant deficit in verbal intelligence as assessed by Adult Reading Test score <85.
boolean
Aphasia
Item
[E24] Cognitive Function 3. Aphasia
boolean
weakness in dominant hand
Item
[E25] Cognitive Function 4. Inability to perform the test due to significant weakness in dominant hand.
boolean
Item Group
Cognitive Function substudy
Item
1. Cognitive function testing completed
text
Code List
1. Cognitive function testing completed
CL Item
Date (-99)
CL Item
Not done (ND)
Date cognitive function testing
Item
1. Date cognitive function testing completed
date

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial